Fondation ophtalmique Adolphe de Rothschild
Paris, 75019, France
NCT Number: NCT02678091
Orbital masses develop at the expense of the orbital structures lacrimal glands, oculomotor muscles, optic nerve, meningeal spaces, peripheral nerves, bone wall, orbital fat, lymphoid structures or vascular structures. These masses can be tumors, benign or malignant, or pseudotumor, mainly represented by specific or non-specific orbital inflammation.
Pathology is of considerable importance for the diagnosis and the treatment of those masses. However, biopsy or surgical resection of the orbital masses is sometimes difficult and dangerous outside expert centers.
The identification of a non-invasive technique for distinguishing tumors from pseudotumors, thus avoid in some cases a biopsy, would be a major contribution for the patients.
Quantitative analysis of the ultrasound exam with doppler of those masses could identify diagnostic criteria, especially for the lacrimal gland, easily explorable.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Paris, 75019, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Ultrasound exam of the orbit
Time frame: One month
Time frame: One month
Fondation Ophtalmologique Adolphe de Rothschild
Network
Contribution of the Quantitative Analysis of the Ultrasound Exam With Doppler for the Etiological Diagnosis of Orbital Masses (PUCE)
Acronym: PUCE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05645341
Bone Diseases, Bone Neoplasms
Guangzhou, Guangdong, China
View Trial DetailsNCT02401906
Bone Diseases, Bone Neoplasms
Paris, France
View Trial DetailsNCT02434120
Bone Diseases, Bone Neoplasms
Paris, France
View Trial DetailsNCT06336499
Bone Diseases, Bone Neoplasms
View Trial Details